Koers Nextage Therapeutics Ltd TEL AVIV STOCK EXCHANGE
Aandelen
NXTG
IL0004330119
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 40 | 12-08-20 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 61 | 10-07-22 |
General Counsel | 53 | 12-08-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yaacov Elinav
BRD | Director/Board Member | 79 | 12-08-20 |
Israel Makov
CHM | Chairman | 84 | 21-11-11 |
Ron Grupel
BRD | Director/Board Member | 73 | 13-10-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,19% | 11,48 mld. | |
+44,16% | 3,3 mld. | |
-19,90% | 2,01 mld. | |
-38,37% | 1,99 mld. | |
-30,21% | 1,42 mld. | |
+16,18% | 1,02 mld. | |
-6,11% | 699 mln. | |
-32,75% | 429 mln. | |
-52,35% | 354 mln. |